+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

High-dose nutraceuticals in human immunodeficiency virus-disease. An understudied option?



High-dose nutraceuticals in human immunodeficiency virus-disease. An understudied option?



Current Topics in Nutraceutical Research 1(1): 1-16



This hypothesis paper outlines the rationale for introduction of nutraceutical-therapy into the context of modern human immunodeficiency virus disease management. Proinflammatory and oxidative stress induced by the immune response mechanisms directed against opportunistic infections and by the human immunodeficiency virus itself are important driving forces in human immunodeficiency virus disease progression.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 003795240

Download citation: RISBibTeXText


Related references

Supplement 2. Treatment Trends in Human Immunodeficiency Virus Disease || Dose-Related Activity of Stavudine in Patients Infected with Human Immunodeficiency Virus. Journal of Infectious Diseases 171: S131-S139, 1995

High frequency of human immunodeficiency virus-associated autonomic neuropathy and more severe involvement in advanced stages of human immunodeficiency virus disease. Archives of Internal Medicine 151(12): 2441-2443, 1991

Pharmacokinetic evaluations of low- and high-dose zidovudine plus high-dose acyclovir in patients with symptomatic human immunodeficiency virus infection. Antimicrobial Agents and ChemoTherapy 35(11): 2225-2231, 1991

Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma. Cancer 98(6): 1196-1205, 2003

High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease. Haematologica 89(9): 1100-1108, 2004

High-dose fluconazole for treatment of cryptococcal disease in patients with human immunodeficiency virus infection. The California Collaborative Treatment Group. Journal of Infectious Diseases 170(1): 238-242, 1994

Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus. Aids Research and Human Retroviruses 13(17): 1487-1495, 1997

Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particles. Journal of Virology 77(2): 1163-1174, 2003

Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. Centers for Disease Control and Prevention. Mmwr. Recommendations and Reports 48(Rr-13): 1-27, 29-31, 2000

Molecular evolution analysis of the human immunodeficiency virus type 1 envelope in simian/human immunodeficiency virus-infected macaques: implications for challenge dose selection. Journal of Virology 85(19): 10332-10345, 2011

Efficacy of induction therapy with high-dose interferon for patients with hemophilia and human immunodeficiency virus-hepatitis C virus coinfection. Clinical Infectious Diseases 35(12): 1527-1533, 2002

High dose immunoglobulin for human immunodeficiency virus-associated thrombocytopenia. Clinical Research 40(3): 716A, 1992

High-dose glycyrrhizin and human immunoglobulin were effective for cytomegalovirus retinitis in a hemophiliac patient with human immunodeficiency virus. Japanese Journal of Clinical Ophthalmology 48(7): 1357-1362, 1994

Synergistic neutralization of simian-human immunodeficiency virus SHIV-vpu+ by triple and quadruple combinations of human monoclonal antibodies and high-titer anti-human immunodeficiency virus type 1 immunoglobulins. Journal of Virology 72(4): 3235-3240, 1998

Usefulness of Low-Dose Statin Plus Ezetimibe and/or Nutraceuticals in Patients With Coronary Artery Disease Intolerant to High-Dose Statin Treatment. American Journal of Cardiology 123(2): 233-238, 2019